In this post, well summarize two major studies from 2025 that examined the use of GLP-1 receptor agonists in men with prostate cancer
Science translational medicine
TRIUMPH-4 (28.7% weight loss, knee OA population, December 2025), TRIUMPH-1 (28.3%, general obesity, May 2026), TRANSCEND-T2D-1 (-2.0% HbA1c, 16.8% weight loss, June 2026), TRIUMPH-2 (20.8% weight loss, obesity + diabetes, July 23, 2026), and TRIUMPH-3 (22.6% weight loss, obesity + cardiovascular disease, July 23, 2026) have all reported positive results
The FDA has identified fraudulent compounded semaglutide products with labels listing pharmacy names that either do not exist or did not actually compound the product
With a firm grip, snap the top off, making sure to break it away from your body
Heres the Ingredients: Water, Ethylhexyl,Methoxycinnamate,Glycerin,Niacinamide,Butyl Methoxydibenzoymethane,gluthathione,sodium hyaluronate,retinyl palmitate,sunflower seed oil,glycine,cystine,sodium pca,petrolatum,triethanolamine,phenoxyethanol,dimethicone,cyclopentasiloxane,acrylates,benzoic acid,citric acid,potassium hydroxide, potassium carbonate, potassium chloride, iton oxides Your response is hightly appreciated